Centiva Capital, LP - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 84 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Centiva Capital, LP ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2018$55,000
-42.1%
121,720
-35.2%
0.01%
-75.0%
Q2 2018$95,000–187,749–0.02%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2018
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders